Latest Updates on Lipid Management.

Emmanuel Eroume-A EgomRebabonye B PharithiSoressa HesseNeasa StarrRichard ArmstrongHabitha Mohammed SulaimanKatarina GazdikovaIoana MozosMartin CaprndaPeter KubatkaPeter KruzliakBarkat KhanLudovit GasparVincent M G Maher

Published in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2019)

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.

Keyphrases

cardiovascular disease
low density lipoprotein
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
fatty acid
peritoneal dialysis
type diabetes
patient reported outcomes
cardiovascular risk factors
preterm birth